Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2019, Iris Publishers LLC
https://doi.org/10.33552/ABEB.2019.02.000535…
3 pages
1 file
Clinical pharmacists give valuable administrations to grown-up patients, however their advantages for pediatric and neonatal emergency clinic patients are less characterized [1]. The 2016
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
Children warrant access to care from clinical pharmacists trained in pediatrics. The American College of Clinical Pharmacy Pediatrics Practice and Research Network (ACCP Pediatrics PRN) released an opinion paper in 2005 with recommendations for improving the quality and quantity of pediatric pharmacy education in colleges of pharmacy, residency programs, and fellowships. Although progress has been made in increasing the availability of pediatric residencies, there is still much to be done to meet the direct care needs of pediatric patients. The purpose of this joint opinion paper is to outline strategies and recommendations for expanding the quality and capacity of pediatric clinical pharmacy practitioners by elevating the minimum expectations for pharmacists entering pediatric practice, standardizing pediatric pharmacy education, expanding the current number of pediatric clinical pharmacists, and creating an infrastructure for development of pediatric clinical pharmacists and clinical scientists. These recommendations may be used to provide both a conceptual framework and action items for schools of pharmacy, health care systems, and policymakers to work together to increase the quality and quantity of pediatric training, practice, and research initiatives.
American Journal of Health-System Pharmacy
Purpose To summarize recently published research reports and practice guidelines deemed to be significantly impactful for pediatric pharmacy practice. Summary Our author group was composed of 8 board-certified pediatric pharmacists. Eight major themes were identified: critical care, hematology/oncology, medication safety, general pediatrics, infectious diseases, neurology/psychiatry, gastrointestinal/nutrition, and neonatology. The author group was assigned a specific theme(s) based on their practice expertise and were asked to identify articles using MEDLINE and/or searches of relevant journal articles pertaining to each theme that were published from January 2019 through December 2020 that they felt were “significant” for pediatric pharmacy practice. A final list of compiled articles was distributed to the authors, and an article was considered significant if it received a vote from 5 of the 8 authors. Thirty-two articles, including 16 clinical practice guidelines or position stat...
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
Children
This editorial describes the purposes and content of the Special Issue for the development of a national pediatric pharmacotherapy collaborative practice network. A collaborative practice network from a population health perspective is needed to better manage the medication-related needs of children with special health care needs and medical complexity (CSHCN-CMC). Over the last 25 years, the pharmacy profession has been engaged in organized efforts both to elevate practice and educational standards for pediatric pharmacy practice and to design medication management systems that benefit children and their families and caregivers. Moreover, alignment with pediatric clinical pharmacologists will aid in the development of new practice-based research paradigms that can be applied in the clinical setting. Formalized multi-disciplinary collaboration (CPAs) with new approaches to specialized electronic medication systems and comprehensive medication management (CMM) is necessary to improve...
2020
Aims of the study: The aim of this study was to determine pharmacists' perceived knowledge and expertise required to deliver pharmaceutical care services to pediatric patients. Methods used to conduct the study: Once ethical approval was obtained; a questionnaire was posted on local pharmacy groups. The questionnaire is composed of four domains: (1) Demographics (2) Perceived knowledge of pediatric treatment and dosing (3) Real life pediatric cases (4) Future aspirations to enhance pediatric pharmacy. Results of the study: Two-hundred questionnaires where complete and submitted online. Most participants (62.5%) practiced in a community setting. Most respondents (40%) reported that 41%-60% of their patients were pediatrics. In general, respondents had a good perception of their knowledge and expertise to deliver pharmaceutical care services to pediatric patients. However, most respondents had a low knowledge score when faced with real-life pediatric cases. On a scale of seven most respondents obtained the score of two (32.0%). Conclusions drawn from the study and clinical implications: The present study sheds the light on an alarming lack of knowledge in pediatric knowledge amongst pharmacies in Jordan. Further training and educational programs should be implemented to address this gap in knowledge and its reflections on practice.
Current aspects of military medicine, 2023
Introduction. In the world, the issue of Good Pharmacy Practice standards is taken care of by several international organizations-WHO, the International Pharmaceutical Federation and the European Directorate for the Quality of Medicines. However, each state determines the priority components of pharmaceutical activity, which should be subject to mandatory state regulation. Pharmaceutical practice, provision of pharmaceutical care and pharmaceutical services by retail entities of medicines in Ukraine is carried out in compliance with the requirements of Good Pharmacy Practice (GPP), which is approved by the central executive body that ensures the formation and implementation of state policy in the field of health care as an industry standard in the form of guidelines. GPP and post-registration efficiency studies are approved by the central executive body that ensures the formation and implementation of state policy in the field of health care as industry standards in the form of guidelines adapted to the relevant requirements established by the European Union. The purpose of the study was to determine the role of the pharmacist in the context of pharmacovigilance during the provision of pharmaceutical care in pediatric practice. Materials and methods. During the writing of the article, we used general scientific theoretical methods, such as bibliographic, system analysis, generalization, system approach, and information synthesis. The results and their discussion. Recently, there have been significant changes in the current role of pharmacists in their efforts to solve global problems of national healthcare systems, primarily in terms of improving accessibility, ensuring the quality of pharmaceutical care and services, as well as the rational use of limited healthcare resources. According to available data in the medical literature, the current trends in the practice of pharmacists in modern society have been identified (integrated model of pharmaceutical care and services development). Only calculated doses of the drug should be prescribed for children in accordance with age and body weight. A preliminary test for tolerance and sensitivity to the prescribed drug should be conducted (possibly on the mother of the child), considering the functional state of the vital organs of the body. Conclusion. Role of the pharmacist is increasing recently. Expanding competencies of the pharmacist in providing pharmaceutical care to patients, in particular representatives of the pediatric population, the functioning of the principles of pharmaceutical care at the proper level and maintaining communication in «Сучасні аспекти військової медицини. Current Aspects of Military Medicine» (2023, 30-1) 13 the triangle "doctor-pharmacist-patient" in order to maintain the quality of life of the patient in the up-to-date health care system are becoming important given the need for timely retraining and advanced training of pharmacists to improve their understanding of the anatomical and physiological features of the development of the child's body and ensure compliance to treatment.
The Canadian Journal of Hospital Pharmacy, 2009
Pharmacy, 2021
Paediatric patients are unique, yet challenging patients to care for by pharmacists. Paediatric medicine use requires special consideration. Pharmacists play an important role in educating and counselling patients, carers, and healthcare workers. Further, pharmacists have the necessary knowledge and skills to optimise safe medicine use in paediatric patients. This article provides basic principles for safe practices in paediatric medicine by following the nine rights of medication administration.
American Journal of Health-System Pharmacy, 2008
OBJECTIVE: The objective of this study is to determine the nature and severity of adverse drug reactions (ADRs) in pediatric patients. MATERIALS AND METHODS: In this retrospective cohort study, we extracted the data from all the available pediatric ADR forms submitted to ADR monitoring center (AMC) from May 2014 to December 2016. The data including nature, frequency, causality (World Health Organization [WHO] causality scale), and the severity (Hartwig and Siegel scale for severity) of ADR were extracted. We also assessed the preventability of the event on modified Schumock and Thornton scale of ADR preventability. RESULTS: There were a total of 20 pediatric ADRs reported during this period. Nearly two-thirds of the ADRs occurred in patients who were receiving multiple drugs (polytherapy). Antimicrobial agents were the most commonly implicated drugs. The most common ADRs were skin rash (maculopapular, erythematous, and urticaria, itching, etc.). The severity and preventability scales indicated that most reactions (18/20) were moderate in nature and all were preventable. Four reactions were "certainly" and ten ADRs were "probably" related to the suspected drug as determined by the WHO causality assessment. CONCLUSION: Frequency of ADR increased with number of medications patient was receiving. Health-care providers (HCPs) involved in the care of children must be aware of this fact and should use additional drugs when absolutely necessary. They should be involved in pharmacovigilance program by exchanging and updating each other through sharing constructive information, communication, and education concerning the appropriate use of drugs in children. Pediatric pharmacovigilance is the need of the hour and should be given utmost importance for monitoring the safety of drugs in children. Motivating HCPs for voluntary reporting of ADRs for preventing the morbidity and mortality in this vulnerable population could be of immense importance.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
South African pharmaceutical journal. Suid-Afrikaanse tydskrif vir apteekwese
Research in Social & Administrative Pharmacy, 2017
Journal of Emergency Nursing, 2008
Canadian Pharmacists Journal, 2020
The Canadian journal of hospital pharmacy, 2014
The Journal of Pediatric Pharmacology and Therapeutics, 2016
The Journal of Pediatric Pharmacology and Therapeutics, 2020
The Journal of Pediatric Pharmacology and Therapeutics
Revista Brasileira de Enfermagem, 2022
BMC pharmacology & toxicology, 2017
International Journal of Basic & Clinical Pharmacology
Hospital pediatrics, 2016
Critical Care Nursing Quarterly, 2012
Revista de Ciências Farmacêutica Básica e Aplicadas - RCFBA